Interferon-ɑ-induced pure red cell aplasia following chronic myelogenous leukemia
- 1 January 2001
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Anti-Cancer Drugs
- Vol. 12 (1), 7-8
- https://doi.org/10.1097/00001813-200101000-00002
Abstract
We report a case of pure red cell aplasia (PRCA) that resulted from interferon (IFN)-alpha therapy for chronic myelogenous leukemia. PRCA improved within 1 month after IFN-alpha was discontinued. This case indicates the involvement of IFN-alpha in the pathogenesis of PRCA.Keywords
This publication has 5 references indexed in Scilit:
- Pure red cell aplasia in a patient with chronic granulocytic leukaemia treated with interferon-αClinical and Laboratory Haematology, 2000
- Acquired pure red cell aplasia in JapanEuropean Journal of Haematology, 1997
- Chronic myeloid leukemia associated with pure red cell aplasia and terminating in promyelocytic transformationAmerican Journal of Hematology, 1989
- The possible involvement of interferons in acquired pure red cell aplasiaAmerican Journal of Hematology, 1988
- Red Cell Aplasia and Chronic Granulocytic LeukaemiaBritish Journal of Haematology, 1981